Mayo Clinic, Minnesota, United States
Grzegorz (Greg) Nowakowski, M.D., is a consultant and a Professor of Medicine and Oncology, Division of Hematology at Mayo Clinic in Rochester, Minnesota, where he also serves as the vice-Chair of Lymphoma Group and Division of Hematology and Deputy Director of Mayo Clinic Comprehensive Cancer Center for Clinical Reserch.
Dr. Nowakowski’s research focuses on the molecular classification and biology of lymphoproliferative disorders, new approaches to clinical trial design and novel therapies for lymphoma . Dr. Nowakowski currently serves as the chair of ASH Clinical Trial Innovation Subcommittee and chair of ASCO Clinical Trial Access and Participation Taskforce. Dr. Nowakowski has significant regulatory experience, both serving as a PI of regulatory studies and working with regulatory agencies, including his service as a Voting Member of the Oncology Drugs Advisory Committee (ODAC) to the Food and Drug Administration (FDA). Dr. Nowakowski has authored over 240 articles and numerous book chapters and mentored many faculty members in US and abroad.
Dr. Nowakowski received his MD from the Medical University of Warsaw, Poland. He completed his internal medicine residency at Yale University Medical School - Norwalk Hospital, Norwalk, Connecticut and his fellowship in Hematology and Medical Oncology at Mayo Clinic, Rochester, Minnesota. Dr Nowakowski joined the Mayo Clinic Lymphoma Group in 2006 as a Mayo Foundation Scholar. He is an alumnus of the American Society of Hematology (ASH) Clinical Research Training Institute and American Society of Clinical Oncology (ASCO) Leadership Development Program.
Disclosure information not submitted.
Saturday, October 22, 2022
2:00 PM – 4:10 PM
Saturday, October 22, 2022
3:35 PM – 3:55 PM
Saturday, October 22, 2022
3:55 PM – 4:10 PM